Top credit ranking Johnson & Johnson reportedly sold USD3.5 billion in a six-part bond issue, its first offering in the last two years. Proceeds from the deal will be used to pay the health care product manufacturer's outstanding debt.
Tags: Johnson & Johnson
Apps put fitness fans through short, sharp workouts
Fitness buffs who can't make it to the gym but still want to exercise can turn to apps for a short, intense workout when they are pressed for time. The U.S. Centers for Disease Control recommend that adults do at least 150 minutes of moderate aerobic activity weekly. But recent studies suggest even short bouts of exercise can have positive health effects.
Chicago software firm Wellspring bags $3.5M in funding
Illinois, US-based software systems provider Wellspring Worldwide bagged $3.5 million in funding from undisclosed investors, according to a document filed with the US Securities and Exchange Commission.
Carlyle acquires J&J unit, joins others in making purchases in the New Year
As the New Year starts to roll, private equity firm Carlyle joins the other firms racing to make acquisitions with its $4.15 billion purchase of a Johnson&Johnson unit, the Financial Times reported.
Pharmaceutical firms introduce new drugs but encounter selling difficulties- report
After lackluster activity in the past years, pharmaceutical firms have gotten back to producing new drugs but they encounter challenges in selling them, according to a report on The Wall Street Journal.
Latest News
US-based generic drug manufacturer Mylan and two Indian pharmaceutical firms are in talks to buy Chennai-based Bafna Pharmaceuticals for an undisclosed amount, according to two sources familiar with the transaction.
Only three potential buyers from at least five who expressed initial interest were left to bid for the Ortho Clinical Diagnostics business of healthcare firm Johnson & Johnson, according to sources interviewed by Bloomberg.
Sources name the Carlyle Group LP and a combined group from Danaher Corp and Blackstone Group LP to have successfully advanced to the final stage of sale negotiations for J&J's diagnostics unit
Healthcare company Johnson & Johnson stopped selling some of its products to Amazon.com because of complaints about the site's third party sellers.
Many private equity firms and partnerships are in the process of formulating their bids for diagnostic unit of Johnson&Johnson.
Johnson & Johnson received numerous preliminary offers from hedge funds interested in acquiring its Ortho Clinical Diagnostics unit, said a Reuters report.
Johnson & Johnson had launched a sale process for its Ortho Clinical Diagnostics unit valued at USD5 billion.
Energizer Holdings planned to acquire Johnson & Johnson's feminine care line for US$185 million.
Kinetic Concepts Inc. revealed that they had signed an investment agreement to acquire Systagenix for US$485 million.
